Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 856532, 6 pages
http://dx.doi.org/10.1155/2015/856532
Research Article

The Increased Expression of CCL20 and CCR6 in Rectal Mucosa Correlated to Severe Inflammation in Pediatric Ulcerative Colitis

Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan

Received 15 October 2014; Accepted 5 January 2015

Academic Editor: Paolo Gionchetti

Copyright © 2015 Keiichi Uchida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Jakobsen, J. Bartek Jr., V. Wewer et al., “Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease—a population-based study,” Alimentary Pharmacology & Therapeutics, vol. 34, no. 10, pp. 1217–1224, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Van Limbergen, R. K. Russell, H. E. Drummond et al., “Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease,” Gastroenterology, vol. 135, no. 4, pp. 1114–1122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. C. A. Haller and J. Markowitz, “IBD in children: lessons for adults,” Current Gastroenterology Reports, vol. 9, no. 6, pp. 528–532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Zhang, Y. Zhang, W. Zhong, C. Di, X. Lin, and Z. Xia, “Heme oxygenase-1 ameliorates dextran sulfate sodium-induced acute murine colitis by regulating Th17/Treg cell balance,” The Journal of Biological Chemistry, vol. 289, no. 39, pp. 26847–26858, 2014. View at Publisher · View at Google Scholar
  5. B. Singh, S. Read, C. Asseman et al., “Control of intestinal inflammation by regulatory T cells,” Immunological Reviews, vol. 182, pp. 190–200, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Schutyser, S. Struyf, and J. van Damme, “The CC chemokine CCL20 and its receptor CCR6,” Cytokine & Growth Factor Reviews, vol. 14, no. 5, pp. 409–426, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. I. R. Williams, “CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis,” Annals of the New York Academy of Sciences, vol. 1072, pp. 52–61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Izadpanah, M. B. Dwinell, L. Eckmann, N. M. Varki, and M. F. Kagnoff, “Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 280, no. 4, pp. G710–G719, 2001. View at Google Scholar · View at Scopus
  9. J. H. Kwon, S. Keates, L. Bassani, L. F. Mayer, and A. C. Keates, “Colonic epithelial cells are a major site of macrophage inflammatory protein 3α (MIP-3α) production in normal colon and inflammatory bowel disease,” Gut, vol. 51, no. 6, pp. 818–826, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kaser, O. Ludwiczek, S. Holzmann et al., “Increased expression of CCL20 in human inflammatory bowel disease,” Journal of Clinical Immunology, vol. 24, no. 1, pp. 74–85, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. D. N. Cook, D. M. Prosser, R. Forster et al., “CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue,” Immunity, vol. 12, no. 5, pp. 495–503, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Varona, V. Cadenas, J. Flores, A. C. Martínez, and G. Márquez, “CCR6 has a non-redundant role in the development of inflammatory bowel disease,” European Journal of Immunology, vol. 33, no. 10, pp. 2937–2946, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Hiwatashi, “The diagnostic criteria for determination of ulcerative colitis severity,” in The 1993 Annual Report of the Research Committee of Inflammatory Bowel Disease, pp. 90–92, Ministry of Health and Welfare of Japan, Tokyo, Japan, 1994. View at Google Scholar
  14. K. Geboes, R. Riddell, A. Öst, B. Jensfelt, T. Persson, and R. Löfberg, “A reproducible grading scale for histological assessment of inflammation in ulcerative colitis,” Gut, vol. 47, no. 3, pp. 404–409, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Ghadjar, C. Rubie, D. M. Aebersold, and U. Keilholz, “The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer,” International Journal of Cancer, vol. 125, no. 4, pp. 741–745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. J. Campbell, J. Hedrick, A. Zlotnik, M. A. Siani, D. A. Thompson, and E. C. Butcher, “Chemokines and the arrest of lymphocytes rolling under flow conditions,” Science, vol. 279, no. 5349, pp. 381–384, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Homey, M.-C. Dieu-Nosjean, A. Wiesenborn et al., “Up-regulation of macrophage inflammatory protein-3alpha/CCL20 and CC chemokine receptor 6 in psoriasis,” Journal of Immunology, vol. 15, pp. 6621–6632, 2000. View at Google Scholar · View at Scopus
  18. H. Zhang, W. Zhong, G. Zhou, X. Ding, and H. Chen, “Expression of chemokine CCL20 in ulcerative colitis,” Molecular Medicine Reports, vol. 6, no. 6, pp. 1255–1260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Teramoto, S. Miura, Y. Tsuzuki et al., “Increased lymphocyte trafficking to colonic microvessels is dependent on MAdCAM-1 and C-C chemokine mLARC/CCL20 in DSS-induced mice colitis,” Clinical and Experimental Immunology, vol. 139, no. 3, pp. 421–428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Katchar, C. P. Kelly, S. Keates, M. J. O'Brien, and A. C. Keates, “MIP-3α neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 292, no. 5, pp. G1263–G1271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. H. J. Lee, S. C. Choi, M. H. Lee et al., “Increased expression of MIP-3alpha/CCL20 in peripheral blood mononuclear cells from patients with ulcerative colitis and its down-regulation by sulfasalazine and glucocorticoid treatment,” Inflammatory Bowel Disease, vol. 11, pp. 1070–1079, 2005. View at Publisher · View at Google Scholar
  22. K. Hashimoto, S. Saigusa, T. Araki et al., “Correlation of CCL20 expression in rectal mucosa with the development of ulcerative colitis-associated neoplasia,” Oncology Letters, vol. 6, no. 5, pp. 1271–1276, 2013. View at Publisher · View at Google Scholar · View at Scopus